3-D Matrix, Ltd. (DMTRF)

USD 0.69

(0.0%)

Market Cap (In USD)

69.64 Million

Revenue (In USD)

4.58 Billion

Net Income (In USD)

-255.5 Million

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.69-1.11
PE
-
EPS
-
Beta Value
0.517
ISIN
JP3410730000
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Jun Okada
Employee Count
-
Website
https://www.3d-matrix.co.jp
Ipo Date
2013-06-19
Details
3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.